Parameter
| Biomarker | CK-MB | Full name | Creatine kinase MB isoenzyme | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | 86 kDa | Core Functional Dimensions | Diagnosis, assessment of the condition |
| Disease | Coronary heart disease (CHD) | Disease Subtypes | / | ||
| Organ | Myocardium, skeletal muscle (minor) | Test Sample / Technology Platform | Whole blood/plasma (immunoturbidimetry, mass spectrometry) | ||
| Pathobiological Mechanisms | Enzymes released after myocardial injury, level changes reflect infarction range, also can evaluate reperfusion therapeutic effect | ||||
| Clinical Availability Status | Clinical routine/validation: auxiliary cTn diagnosis, supplementary assess the degree of myocardial injury, especially for reperfusion efficacy monitoring | ||||
| Notes and Dynamics | Percutaneous coronary intervention (PCI) after 12 hours of CK-MB level, can accurately predict the forward area of myocardial infarction (MI), guiding the follow-up treatment | ||||